SIMCERE PHARMA (02096) spent 10.1667 million Hong Kong dollars to repurchase 1.49 million shares on November 18th.
Sinopharm (02096) announced that on November 18, 2024, the company invested 1016.67 million...
SIMCERE PHARMA (02096) announced that on November 18, 2024, the company repurchased 1.49 million shares at a cost of 10.167 million Hong Kong dollars. The repurchase price was between 6.71 and 6.98 Hong Kong dollars per share.
Related Articles
Guotai Haitong: Liquidity crisis eased, gold returns to an upward trend.
China Securities Co., Ltd.: China has a competitive advantage in the rare earth industry chain. In the future, attention will be paid to the demand for neodymium iron boron materials driving the industry.
Guotai Haitong: Entering the super cycle of storage, focusing on the price elasticity of consumer storage.
Guotai Haitong: Liquidity crisis eased, gold returns to an upward trend.
China Securities Co., Ltd.: China has a competitive advantage in the rare earth industry chain. In the future, attention will be paid to the demand for neodymium iron boron materials driving the industry.
Guotai Haitong: Entering the super cycle of storage, focusing on the price elasticity of consumer storage.
RECOMMEND
Energy Storage Industry Set To Ride the AI Tailwind; UBS: Global Demand May Surge 40% Next Year
13/11/2025
Double Eleven’s Cooling To A Historic Low? A Necessary Step Toward E‑commerce Maturity
13/11/2025
On The Eve of L3 Mass Commercialization: How Autonomous Driving Will Reconfigure a Trillion‑Yuan Service Market
13/11/2025
